Kevin Foley

Kevin is an experimental biologist with expertise in biochemistry, cell biology, and physiology. He has over 10 years of experience studying metabolic and inflammatory disease, with a focus on Type 2 Diabetes and aging. In his work, Kevin has developed both in vivo and in vitro models and published 28 peer-reviewed scientific papers. His postdoctoral work at McMaster University in Ontario, Canada focused on host-microbe interactions in regulating glucose homeostasis during the progression of insulin resistance. Kevin’s expertise supports Siolta’s ongoing development of therapeutics to address metabolic disease.